Publication | Closed Access
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity
147
Citations
15
References
2014
Year
Real-life data confirm nabiximols as an effective and well-tolerated treatment option for resistant MSS in clinical practice.
| Year | Citations | |
|---|---|---|
Page 1
Page 1